President Donald Trump and the pharmaceutical giant Pfizer are set to announce an agreement to lower medication costs for Medicaid patients , advancing Trump’s “Most Favored Nation” pricing effort to reduce the cost of American prescription drugs.

Senior administration officials confirmed to the Washington Examiner Tuesday morning that Trump and Pfizer CEO Albert Bourla are set to announce a cost-cutting measure at the White House later Tuesday.

Recommended Stories

Trump 'most favored nation' drug price negotiations extend past deadline

GOP nears schism over hepatitis B vaccinations

Thune dismisses Democrats' demand to reach Obamacare subsidies deal before shutdown

In May, Trump signed an executive order that laid out the Most Favored Nation drug pricing policy meant to bri

See Full Page